- Home
- RIGL vs GNTY Comparison
RIGL vs GNTY Comparison
Compare RIGL & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- GNTY
- Stock Information
- Founded
- RIGL 1996
- GNTY 1913
- Country
- RIGL United States
- GNTY United States
- Employees
- RIGL N/A
- GNTY N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- GNTY Major Banks
- Sector
- RIGL Health Care
- GNTY Finance
- Exchange
- RIGL Nasdaq
- GNTY Nasdaq
- Market Cap
- RIGL 486.4M
- GNTY 399.9M
- IPO Year
- RIGL 2000
- GNTY 2017
- Fundamental
- Price
- RIGL $20.99
- GNTY $41.30
- Analyst Decision
- RIGL Buy
- GNTY Hold
- Analyst Count
- RIGL 5
- GNTY 3
- Target Price
- RIGL $34.80
- GNTY $37.33
- AVG Volume (30 Days)
- RIGL 216.6K
- GNTY 57.9K
- Earning Date
- RIGL 03-04-2025
- GNTY 01-21-2025
- Dividend Yield
- RIGL N/A
- GNTY 2.31%
- EPS Growth
- RIGL N/A
- GNTY 7.03
- EPS
- RIGL 0.22
- GNTY 2.74
- Revenue
- RIGL $157,374,000.00
- GNTY $120,816,000.00
- Revenue This Year
- RIGL $51.34
- GNTY N/A
- Revenue Next Year
- RIGL $15.75
- GNTY $5.33
- P/E Ratio
- RIGL $94.25
- GNTY $15.17
- Revenue Growth
- RIGL 21.65
- GNTY 1.11
- 52 Week Low
- RIGL $7.48
- GNTY $27.01
- 52 Week High
- RIGL $29.82
- GNTY $42.95
- Technical
- Relative Strength Index (RSI)
- RIGL 55.77
- GNTY 63.11
- Support Level
- RIGL $20.98
- GNTY $40.00
- Resistance Level
- RIGL $23.01
- GNTY $42.95
- Average True Range (ATR)
- RIGL 1.40
- GNTY 1.38
- MACD
- RIGL 0.31
- GNTY 0.24
- Stochastic Oscillator
- RIGL 70.13
- GNTY 70.79
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.